drugset / Trial / NCT00005023
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to tumor cells. Colony-stimulating factors such as sargramostim increase the number of immune cells found in bone marrow or peripheral blood. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy plus sargramostim in treating patients who have stage III or stage IV cancer.
Timeline
- Start
- 1999-03
- Primary completion
- 2001-01
- Completion
- 2001-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HER-2/neu peptide vaccine | Vaccine | — | Intravenous |
| Background | sargramostim | Protein / enzyme biologic | — | — |